David Bryson, PhDDirector, Gene Editing at Beam TherapeuticsSpeaker
Profile
David is a Director of Gene Editing and Platform Technologies at Beam Therapeutics. David oversees protein engineering and directed-evolution efforts focused on lead optimization and platform development. He joined Beam in 2017 after completing postdoctoral research focused on directed evolution and genetic code expansion applications at Harvard and the Broad Institute. He obtained his PhD in Chemistry from Virginia Tech.
Agenda Sessions
Introduction to Base Editing Technology and Applications
, 9:25amView Session